CAPR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

Capricor Therapeutics (NASDAQ:CAPR) Given "Buy" Rating at HC Wainwright

CAPR DEADLINE MONDAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important September 15 Deadline in Securities Class Action - CAPR

Capricor Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before September 15, 2025 to Discuss Your Rights - CAPR

Securities Lawsuit Alert: Capricor Therapeutics, Inc. (CAPR) - Contact Levi & Korsinsky Before September 15, 2025